Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker AnalysisYuqin Song, Quanli Gao, Huilai Zhang, et al.Cell Reports. Medicine|December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Yun Zhang, Ran Chen, et al.Neoplasia (New York, N.Y.)|July 12, 2020
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumorYao Xiong, Yin Guo, Ye Liu, et al.Frontiers in Immunology|March 11, 2022
An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical ModelsXin Chen, Liu Xue, Xiao Ding, et al.Frontiers of Medicine|September 25, 2023
BGB-A445, a novel non-ligand-blocking agonistic anti-OX40 antibody, exhibits superior immune activation and antitumor effects in preclinical modelsBeibei Jiang, Tong Zhang, Minjuan Deng, et al.Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.Journal of Medical Genetics|May 20, 2015
Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorderLiang Zong, Jing Guan, Megan Ealy, et al.Cell|March 18, 2025
Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifsYong Jiang, Anran Dai, Yuwei Huang, et al.Blood Advances|February 5, 2024
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemiaConstantine S Tam, Stephen Opat, Shirley D'Sa, et al.Pageof 4